Phase 2 Trial of Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
Latest Information Update: 04 Dec 2023
At a glance
- Drugs Cannabidiol (Primary) ; LHRH receptor agonists
- Indications Arthralgia
- Focus Therapeutic Use
- 28 Nov 2023 Status changed from active, no longer recruiting to completed.
- 17 Jul 2023 Status changed from recruiting to active, no longer recruiting.
- 13 Jun 2023 Planned End Date changed from 1 Feb 2023 to 1 Oct 2023.